‘First Mover to Game Changer’: Celltrion announces 2020-2030 strategy at the 38th J.P. Morgan Healthcare Conference. Celltrion’s Chairman Jung Jin Seo outlined the company’s strategic transition: Celltrion expects to transform from a ‘first mover’ to a ‘game changer’ by 2030.
v European Medical Advisory Board on Value Added Medicines. Perceptions and recommendations of physicians/ KOLs on value added medicines. 2019. Available at https://www.medicinesforeurope.com/wp-content/uploads/2019/11/Advisory-board_report-exec-summary_final.pdf [Last accessed January 2020]